Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Ascletis Pharma Inc. announced that expansion of its ritonavir oral tablet production capacity, to approximately 530 million tablets per year, to meet the potential escalation in the domestic and global demands.
read more
The microalgae market is expected to reach $1.77 billion by 2028, at a CAGR of 10.3% during the forecast period 2021 to 2028, according to a report by Meticulous Research®.
read more
Evonik now offers EUDRATEC® SoluFlow, a new microparticle technology to enhance solubility of active pharmaceutical ingredients in oral drug products.
read more
According to a new market research report titled "Probiotics Market by Strain (Bacteria [Bacillus]), by Product Type (Dairy Food [Yogurt, Baked Food]), by Form (Liquid), by Sales Channel (Super Markets, Pharmacies), by End User (Human [Adults, Senior], Animal), and Geography—Global Forecast to 2027", published by Meticulous Research®, the ...
read more
Rigel Pharmaceuticals, Inc. announced the publication of data in the American Journal of Hematology from the open label, multicenter, Phase 2 clinical study of fostamatinib in adults with warm antibody autoimmune hemolytic anemia (wAIHA) who had failed at least one prior treatment.
read more
Cortexyme, Inc., a biopharmaceutical company developing therapies for patients diagnosed with degenerative diseases, announced results from the single ascending dose (SAD) portion of the Phase 1 clinical trial of its new drug candidate COR588, a next-generation, oral, small-molecule lysine gingipain inhibitor in development for the treatment of ...
read more
Enteris BioPharma, a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation, published a white paper entitled, "HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity."
read more
Bayer announced the appointment of Michael Parrish to the position of Vice President of Public Affairs, Science and Sustainability, U.S
read more
The "Capsule Filling Machine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Manual Capsule Filling Machines, Semi-Automatic Capsule Filling Machines, and Fully Automatic Capsule Filling Machines), Application (Pharmaceutical, Cosmetics, Others), and Capacity" report has been added to ResearchAndMarkets.com's offering.
read more
Pfizer Canada ULC is recalling all lots of Accuretic (quinapril hydrochloride and hydrochlorothiazide) medication in 10/12.5 mg, 20/12.5 mg and 20/25 mg strengths due to the presence of a nitrosamine impurity (N-nitroso-quinapril) above the acceptable level.
read more
The U.S. Food and Drug Administration finalized guidance to help companies prepare to quickly and effectively remove violative products from the market.
read more
Athena Bioscience, LLC announced the commercial launch of Nexiclon XR, the only once-daily clonidine extended-release tablets indicated for treatment of hypertension.
read more
Aceto, a supplier for life sciences and advanced technology specialty ingredients, announced the acquisition of Biotron Laboratories and Talus Mineral Company (affiliated entities collectively referred to as Biotron herein), manufacturers of specialty ingredients for the nutritional supplements industry.
read more
Senores Pharmaceuticals, Inc. announced the launch of Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg, a therapeutic equivalent version of MEXITIL (Mexiletine Hydrochloride) with one of the top 5 generic pharmaceutical companies in the U.S. market.
read more
The global empty capsules market was valued at $2,382.7 million in 2020, and is projected to reach $5,230.4 million by 2030, registering a CAGR of 8.1% from 2021 to 2030, according to a report by ResearchandMarkets.com.
read more